FBLG

FibroBiologics, Inc. Common Stock FBLG

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode FBLG DARE ATHA ADTX AIMD CTXR MBRX LPTX APLM ICU
6M -66.87 % -17.49 % 137.95 % -99.35 % -17.43 % -39.80 % -51.55 % 318.31 % 180.66 % -42.37 %
YTD -88.15 % -32.61 % 31.09 % -99.98 % -20.40 % -79.37 % -91.19 % -63.66 % 66.57 % -87.59 %
1Y -89.79 % -34.24 % 33.77 % -99.98 % -17.08 % -75.81 % -91.19 % -60.74 % 71.50 % -88.42 %
3Y -99.19 % -78.47 % -75.81 % -100.00 % -87.33 % -96.02 % -99.06 % -72.98 % -98.26 % -99.77 %
5Y -99.19 % -86.20 % -97.74 % -100.00 % -96.53 % -97.01 % -99.81 % -94.71 % -98.18 % -99.91 %
10Y -99.19 % -99.50 % -95.79 % -100.00 % -96.53 % -99.88 % -99.98 % -98.51 % -98.18 % -99.91 %
From the beginning -99.19 % -99.74 % -95.79 % -100.00 % -96.53 % -99.79 % -99.98 % -98.51 % -98.18 % -99.91 %

Dividend